Chr. Hansen Holding A/S Interim Report Q4 2022/23
October 12, 2023 – Company announcement no. 9
Strong performance for the quarter despite a challenging environment
Statement by CEO Mauricio Graber: “Supported by a strong Q4 performance, Chr. Hansen delivered a solid result for the first twelve months of the extended financial year 2022/23 at the upper end of our guidance with 11% organic revenue growth and an EBIT margin b.s.i. of 26.9%. Throughout the year, we have demonstrated the attractiveness of the markets we serve and the resilience of our business model, supported by a robust and agile organization adapting to changing customer requirements in a challenging environment.
Together with Novozymes, we continue the regulatory approval process in relation to the proposed merger with closing expected in the fourth quarter of the calendar year 2023 or the first quarter of the calendar year 2024.”
Q4 2022/23 highlights
- Revenue amounted to EUR 352 million, up 7% from EUR 328 million in Q4 2021/22. Year-to-date (September 1, 2022 – August 31, 2023) revenue amounted to EUR 1,334 million, up 10% from the same period in 2021/22.
- Organic growth was 16%, equally supported by both business areas. The Lighthouses delivered 41% organic growth combined in Q4, mainly driven by HMO, while the core businesses delivered 14% organic growth. Year-to-date Group organic growth was 11%. The Lighthouses delivered 24% organic growth, while the core businesses delivered 10% organic growth.
- EBIT b.s.i. amounted to EUR 99 million, up 8% from EUR 91 million in Q4 2021/22. The increase was driven by volume growth, a positive contribution from pricing initiatives, and stable operating expenses, which was partly offset by the negative impact of higher input costs and exchange rates.
- The EBIT margin b.s.i. was 28.0%, compared to 27.9% in Q4 2021/22, as the strong sales development including the impact from pricing initiatives were offset by the negative impact of higher input costs and exchange rates.
- Free cash flow b.a.s.i. amounted to EUR 202 million for the year to date, up 17% from EUR 172 million in the same period last year, driven by the improvement in operating profit and lower taxes paid, which was partly offset by a negative change in working capital.
Interim dividend for the period September 1, 2022 – August 31, 2023
In connection with the merger agreement, Novozymes and Chr. Hansen have agreed on certain specific provisions in respect of distributions to their shareholders until completion of the proposed merger. Consistent with the merger agreement with Novozymes, the Board of Directors has decided to declare an interim dividend of DKK 7.72 or EUR 1.04 per share. The total dividend of EUR 137 million is equivalent to 55% of the adjusted profit for the period September 1, 2022 to August 31, 2023, and will be paid on October 17, 2023 (ex-dividend date of October 13, 2023).
Follow-up on 12-month outlook, September 1, 2022 – August 31, 2023
- Organic revenue growth of 11% (outlook July 6, 2023 9-11%)
- EBIT margin b.s.i. of 26.9% (outlook July 6, 2023 26-27%)
- Free cash flow b.a.s.i. of EURm 202 (outlook July 6, 2023 EURm 200-230)
Outlook, January 1, 2023 – December 31, 2023
In light of the performance for the first eight months of 2023, the outlook is adjusted for organic revenue growth and free cash flow b.a.s.i., while maintained for EBIT margin b.s.i. Organic growth for the remaining four months of 2023 is expected to be driven primarily by price growth including a positive impact from EUR-based pricing.
- Organic revenue growth is expected in the range of 10-12% (previously 9-12%)
- EBIT margin b.s.i. is expected to be 26-27% (unchanged)
- Free cash flow b.a.s.i. is expected to be around EURm 190-230 (previously EURm 200-250)
The outlook for the calendar year 2023 is based on actual exchange rates until October 11, 2023, and for the remainder of the calendar year 2023 assuming constant exchange rates at the current level of EUR/USD rate of 1.06, compared to 1.09 at the time of the most recent outlook, provided on July 6, 2023. For further details on the outlook for the January 1, 2023 – December 31, 2023, please refer to page 9.
See attachment for full Q4 2022/23 interim report.
Anders Mohr Christensen, VP Group Strategy & Investor Relations, +45 25 15 23 64
Disa Tuominen, Investor Relations Manager, +45 60 38 58 26
About Chr. Hansen
Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen, we are strongly positioned to drive positive change through microbial solutions. We have worked for over 145 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 50,000 microbial strains, have game-changing potential. Matching customer needs and global trends, we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As the world’s most sustainable food ingredients company, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Teledyne’s Contact Image Sensors for high-speed, high-resolution line scan are now in production30.11.2023 14:00:00 CET | Press release
WATERLOO, Ontario, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Teledyne DALSA is pleased to announce that its AxCIS™ family of high-speed and high-resolution fully integrated line scan imaging modules are in production. These easy-to-use Contact Image Sensors (CIS) combine sensors, lenses, and lights all-in-one, offering a lower cost inspection system for many demanding machine vision applications. Powered by Teledyne’s multiline CMOS image sensors, AxCIS delivers superior image quality, up to 120 kHz line rates for mono, or 60 kHz x 2 for HDR imaging, at a pixel size of 28 µm or 900 dpi resolution, so that defects can be detected with unprecedented precision. Its unique sensor design covers the entire field of view without missing pixels, providing a 100% seamless image without any interpolation. HDR imaging is achieved using dual rows with independent exposure control, which enables better detectability for highly reflective materials with improved dynamic range. In addition to defect detectio
XPENG G9 awarded Norway's People's Favorite Car of the Year Award30.11.2023 13:59:01 CET | Press release
OSLO, Norway, Nov. 30, 2023 (GLOBE NEWSWIRE) -- XPENG Motors ("XPENG" or the "Company," NYSE: XPEV and HKEX: 9868), a leading Chinese smart EV company, becomes the first Chinese car brand to win "People's Favorite 2024", also known as 'folkets favoritt', with the XPENG G9 in Norway's renowned “Car of The Year” awards. "People's Favorite" is part of the prestigious award "Car of the Year 2024" which is carried out for the nineteenth year in a row by Dagbladet in collaboration with media publications Dinside and Elbil24. Readers of Dagbladet, Dinside and Elbil24 in Norway voted for their favorite car for a month, with the XPENG G9 winning with 15.22 percent of the vote. Managing Director of XPeng Motors Norway, Claes Persson, expressed gratitude for this award: "We consider this to be an incredibly distinguished award, especially because the people chose us as the winner. We look forward to developing our current and upcoming electric car models further." Editor in Elbil24, Fred Magne Sk
Delårsrapport for perioden 1. juli – 30. september 202330.11.2023 13:45:00 CET | pressemeddelelse
Nasdaq OMX Copenhagen A/S Charlottenlund, den 30. november 2023 Meddelelse nr. 246 Delårsrapport for perioden 1. juli – 30. september 2023 Bestyrelsen har dags dato behandlet og vedtaget vedhæftede delårsrapport for 3. kvartal 2023. Resultat før værdiregulering og skat for perioden 1. juli til 30. september 2023 udgjorde et overskud på T.EUR 40,0. Resultatet anses som forventet.Negativ værdiregulering på de tyske ejendomme på EUR 3,0 mio.Der er i perioden 1. juli til 30. september 2023 afdraget ekstraordinært EUR 1,0 mio. på lånet hos Ringkjøbing Landbobank, så der samlet for perioden 1. januar til 30. september 2023 er afdraget ekstraordinært i alt EUR 2,0 mio. på lånet hos Ringkjøbing Landbobank.Fortsat betryggende soliditet på 56,4% og likvide reserver på TEUR 3.467,0.Set i lyset af et stadig højt renteniveau forventes et positivt resultat før værdiregulering og skat at ligge i den nedre ende af det udmeldte interval på TEUR 200,0 – 600,0 i 2023.Fokus på fastholdelse af lejere og le
EBVAT for 3. kvartal 2023 – 4,9 mio. kr.30.11.2023 13:44:15 CET | pressemeddelelse
Den 30. november 2023 EBVAT i perioden 1. januar til 30. september 14,9 mio. kr. Samlet resultat er -219,9 mio. kr. i 3. kvartal 2023, Værdiregulering i 3. kvartal 2023 udgør -224,8 mio. kr. Perioden 1. januar til 30. september 2023 For perioden 1. januar til 30. september er det samlede resultat før skat -246,6 mio. kr. Resultatet før kurs- og værdireguleringer (EBVAT) udgør 14,9 mio. kr. Perioden 1. juli til 30. september 2023 EgnsINVEST Ejendomme Tyskland A/S har i 3. kvartal 2023 realiseret et resultat før skat på i alt -219,9 mio. kr., hvoraf -224,8 mio. kr. kan henføres til dagsværdiregulering af investeringsejendomme. Resultatet før kurs- og værdireguleringer (EBVAT) er på 4,9 mio. kr. i perioden. Med baggrund i ejendomsværdireguleringen er selskabets indre værdi faldet med 24,87% til 234,01 i perioden 1. juli til 30. september og børskursen er faldet med 19,47% fra 226 til 182. Selskabets tomgang er 1,06% for boliger og 6,82% for erhverv pr. 30. september, i alt 1,66% (14 lejem
Update: Virtune AB (Publ) is launching Virtune Chainlink ETP on Nasdaq Stockholm30.11.2023 13:35:16 CET | Press release
Stockholm, November 30th, 2023 - Virtune, a Swedish regulated digital asset manager in Sweden is launching a new innovative crypto ETP on Nasdaq Stockholm, the largest stock exchange in the Nordic region. Today, Virtune is announcing the introduction of Virtune Chainlink ETP, providing exposure to Chainlink through a proven and well established financial instrument with a 100% physically backed structure. The ETP which is 100% physically backed and fully collateralized is denominated in SEK for the Swedish audience and is available on Avanza and Nordnet. Chainlink is currently among the top 15 largest cryptocurrencies with a market capitalization of about USD 8,2 billion and has experienced a 165% growth during 2023 year to date. Chainlink acts like a bridge for smart contracts on different blockchains, making them all work together. It does this using a decentralized oracle network, which helps blockchains talk to external things like data feeds, events, and payment methods in a secur